Deprescribing Process in Frailty
Research type
Research Study
Full title
An observational Study of the Deprescribing Process in Frailty in a Falls Service and Qualitative study of Patients’ Perspective Toward This Intervention
IRAS ID
331966
Contact name
Anthony Cox
Contact email
Sponsor organisation
University of Birmingham
Clinicaltrials.gov Identifier
N/A, N/A
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
The proposed study will evaluate deprescribing processes in frailty in current practice. In addition, it aims to explore patients’ views about this process. The study will be conducted in two phases: the quantitative phase and qualitative phase. Study period is one year. In the earlier phase (quantitative phase), observational view of frail patients in Falls service at Solihull hospital, West Midlands, will be undertaken. The required data will be extracted by the pharmacist, who is a part of medical team in Falls service and have dircet access the patients' medical record.This phase will involve analysis of anonymised data.In the late phase (qualitative phase), the patient’s perspective regarding deprescribing processes in Falls service will be qualitatively explored.
Phases (quantitative & Qualitative) will involve the use of NHS facilities, including site, staff and patients, will be addressed.REC name
West Midlands - South Birmingham Research Ethics Committee
REC reference
23/WM/0217
Date of REC Opinion
21 Nov 2023
REC opinion
Further Information Favourable Opinion